| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.841 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.840 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.790 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.786 | |
| skeletal system development | GO:0001501 | 356 | 0.760 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.755 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.737 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.734 | |
| cardiac atrium morphogenesis | GO:0003209 | 23 | 0.719 | |
| oviduct development | GO:0060066 | 3 | 0.718 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.708 | |
| ureteric bud development | GO:0001657 | 94 | 0.694 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.688 | |
| ossification | GO:0001503 | 216 | 0.658 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.657 | |
| camera type eye development | GO:0043010 | 266 | 0.655 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.652 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.648 | |
| urogenital system development | GO:0001655 | 261 | 0.638 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.637 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.628 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.624 | |
| nephron development | GO:0072006 | 109 | 0.622 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.614 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.607 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.607 | |
| head morphogenesis | GO:0060323 | 34 | 0.598 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.592 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.587 | |
| regionalization | GO:0003002 | 337 | 0.583 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.583 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.582 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.576 | |
| chemotaxis | GO:0006935 | 247 | 0.575 | |
| renal vesicle induction | GO:0072034 | 3 | 0.558 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.557 | |
| angiogenesis | GO:0001525 | 201 | 0.554 | |
| renal system development | GO:0072001 | 225 | 0.552 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.550 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.546 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.540 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.538 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.535 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.519 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.513 | |
| artery development | GO:0060840 | 53 | 0.505 | |
| cardiac atrium development | GO:0003230 | 24 | 0.505 | |
| kidney epithelium development | GO:0072073 | 121 | 0.502 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.501 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.496 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.496 | |
| spinal cord development | GO:0021510 | 81 | 0.486 | |
| striated muscle cell development | GO:0055002 | 125 | 0.485 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.484 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.482 | |
| mesonephros development | GO:0001823 | 97 | 0.480 | |
| limb development | GO:0060173 | 166 | 0.476 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.473 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.466 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.465 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.461 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.460 | |
| positive regulation of cardiac muscle tissue growth | GO:0055023 | 15 | 0.459 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.454 | |
| muscle cell development | GO:0055001 | 133 | 0.450 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.449 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.449 | |
| cardiac chamber development | GO:0003205 | 108 | 0.448 | |
| muscle tissue development | GO:0060537 | 308 | 0.447 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.441 | |
| kidney development | GO:0001822 | 213 | 0.441 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.439 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.431 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.429 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.421 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.419 | |
| forebrain development | GO:0030900 | 302 | 0.417 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.413 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.410 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.405 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.405 | |
| positive regulation of cardiac muscle tissue development | GO:0055025 | 19 | 0.401 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.396 | |
| renal tubule development | GO:0061326 | 87 | 0.393 | |
| regulation of ossification | GO:0030278 | 112 | 0.392 | |
| regulation of cell activation | GO:0050865 | 289 | 0.391 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.390 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.389 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.389 | |
| renal outer medulla development | GO:0072054 | 2 | 0.388 | |
| stem cell differentiation | GO:0048863 | 268 | 0.387 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.385 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.380 | |
| olfactory lobe development | GO:0021988 | 32 | 0.379 | |
| ear development | GO:0043583 | 200 | 0.376 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.376 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.373 | |
| connective tissue development | GO:0061448 | 179 | 0.370 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.367 | |
| extracellular structure organization | GO:0043062 | 148 | 0.364 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.357 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.354 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.353 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.351 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.350 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.349 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.348 | |
| placenta development | GO:0001890 | 140 | 0.345 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.341 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.339 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.339 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.335 | |
| regulation of cell motility | GO:2000145 | 236 | 0.334 | |
| regulation of secretion | GO:0051046 | 274 | 0.332 | |
| lung induction | GO:0060492 | 3 | 0.329 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.329 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.328 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.328 | |
| nephron tubule development | GO:0072080 | 84 | 0.327 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.324 | |
| septum primum development | GO:0003284 | 4 | 0.324 | |
| organ growth | GO:0035265 | 117 | 0.323 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.317 | |
| regulation of anagen | GO:0051884 | 1 | 0.313 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.313 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.310 | |
| cardiac septum development | GO:0003279 | 59 | 0.309 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.306 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.306 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.305 | |
| lung development | GO:0030324 | 164 | 0.301 | |
| olfactory bulb development | GO:0021772 | 30 | 0.299 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.299 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.296 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.295 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.293 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.292 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.290 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.290 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.290 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.288 | |
| embryonic placenta development | GO:0001892 | 98 | 0.282 | |
| gastrulation | GO:0007369 | 116 | 0.281 | |
| appendage development | GO:0048736 | 166 | 0.280 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.279 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.279 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.274 | |
| stem cell development | GO:0048864 | 219 | 0.268 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.268 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.265 | |
| spemann organizer formation | GO:0060061 | 2 | 0.265 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.265 | |
| heart morphogenesis | GO:0003007 | 178 | 0.263 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.262 | |
| digestive tract development | GO:0048565 | 190 | 0.261 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.258 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.256 | |
| cervix development | GO:0060067 | 2 | 0.253 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.252 | |
| bone development | GO:0060348 | 120 | 0.252 | |
| tissue migration | GO:0090130 | 68 | 0.251 | |
| nephron epithelium development | GO:0072009 | 92 | 0.251 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.250 | |
| limb morphogenesis | GO:0035108 | 149 | 0.249 | |
| amine metabolic process | GO:0009308 | 45 | 0.247 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.246 | |
| regulation of cell migration | GO:0030334 | 219 | 0.246 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.246 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.245 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.245 | |
| heart trabecula formation | GO:0060347 | 14 | 0.245 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.245 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.244 | |
| developmental maturation | GO:0021700 | 193 | 0.243 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.242 | |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 15 | 0.238 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.235 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.233 | |
| mapk cascade | GO:0000165 | 281 | 0.233 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.232 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.231 | |
| cerebellum formation | GO:0021588 | 1 | 0.229 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.224 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.224 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.224 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.223 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.223 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.223 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.219 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.215 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.215 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.215 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.214 | |
| neuron migration | GO:0001764 | 122 | 0.213 | |
| heart growth | GO:0060419 | 45 | 0.213 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.210 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.209 | |
| foramen ovale closure | GO:0035922 | 1 | 0.208 | |
| nephric duct formation | GO:0072179 | 4 | 0.208 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.205 | Human |
| paramesonephric duct development | GO:0061205 | 3 | 0.205 | |
| forebrain regionalization | GO:0021871 | 25 | 0.204 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.204 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.203 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.202 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.202 | |
| digestive system development | GO:0055123 | 200 | 0.202 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.201 | |
| telencephalon development | GO:0021537 | 186 | 0.201 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.200 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.199 | |
| stem cell proliferation | GO:0072089 | 117 | 0.199 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.199 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.197 | |
| ear morphogenesis | GO:0042471 | 118 | 0.197 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.196 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.194 | |
| cartilage development | GO:0051216 | 140 | 0.194 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.193 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.193 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.193 | Human |
| axonogenesis | GO:0007409 | 274 | 0.192 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.192 | |
| respiratory system development | GO:0060541 | 190 | 0.191 | |
| epithelium migration | GO:0090132 | 63 | 0.191 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.190 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.190 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.190 | |
| left lung development | GO:0060459 | 4 | 0.189 | |
| cardiac conduction system development | GO:0003161 | 12 | 0.188 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.187 | |
| regulation of wound healing | GO:0061041 | 40 | 0.187 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.187 | |
| regulation of heart growth | GO:0060420 | 31 | 0.184 | |
| cell maturation | GO:0048469 | 127 | 0.184 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.184 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.182 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.182 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.181 | |
| cell migration involved in gastrulation | GO:0042074 | 13 | 0.180 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.179 | |
| cell adhesion | GO:0007155 | 329 | 0.178 | Human |
| response to growth factor | GO:0070848 | 198 | 0.178 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.177 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.177 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.177 | |
| atrial septum morphogenesis | GO:0060413 | 11 | 0.176 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.175 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.175 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.174 | |
| primitive streak formation | GO:0090009 | 10 | 0.172 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.171 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.170 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.168 | |
| tendon formation | GO:0035992 | 4 | 0.167 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.167 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.167 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.166 | |
| olfactory bulb interneuron development | GO:0021891 | 7 | 0.165 | |
| ventricular septum development | GO:0003281 | 42 | 0.165 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.164 | |
| cell fate determination | GO:0001709 | 32 | 0.162 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.159 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.157 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.157 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.156 | |
| respiratory tube development | GO:0030323 | 167 | 0.154 | |
| collagen fibril organization | GO:0030199 | 32 | 0.154 | |
| response to acid chemical | GO:0001101 | 111 | 0.154 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.153 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.150 | |
| midgut development | GO:0007494 | 4 | 0.150 | |
| odontogenesis | GO:0042476 | 78 | 0.149 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.149 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.148 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.148 | |
| spinal cord association neuron differentiation | GO:0021527 | 14 | 0.148 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.148 | |
| atrial cardiac muscle tissue development | GO:0003228 | 5 | 0.148 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.147 | |
| regulation of membrane depolarization during action potential | GO:0098902 | 1 | 0.147 | |
| mesoderm formation | GO:0001707 | 62 | 0.147 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.147 | |
| lung morphogenesis | GO:0060425 | 50 | 0.146 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.145 | |
| palate development | GO:0060021 | 76 | 0.144 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.144 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.144 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.143 | |
| atrial septum development | GO:0003283 | 12 | 0.140 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.139 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.138 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.137 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.137 | |
| synapse organization | GO:0050808 | 125 | 0.136 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.135 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.134 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.134 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.134 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.134 | |
| diencephalon morphogenesis | GO:0048852 | 6 | 0.134 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.134 | |
| regulation of protein transport | GO:0051223 | 163 | 0.133 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.132 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.132 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.132 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.132 | |
| cytokine production | GO:0001816 | 319 | 0.132 | |
| axon guidance | GO:0007411 | 141 | 0.131 | |
| positive regulation of cartilage development | GO:0061036 | 18 | 0.130 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.130 | |
| bone morphogenesis | GO:0060349 | 78 | 0.130 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.130 | |
| cell fate commitment | GO:0045165 | 210 | 0.130 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.130 | |
| skin development | GO:0043588 | 220 | 0.130 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.128 | |
| synaptic transmission | GO:0007268 | 329 | 0.127 | |
| hematopoietic stem cell proliferation | GO:0071425 | 13 | 0.126 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.125 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.125 | |
| tricuspid valve development | GO:0003175 | 3 | 0.125 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.125 | |
| somitogenesis | GO:0001756 | 69 | 0.124 | |
| limbic system development | GO:0021761 | 72 | 0.123 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.123 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.123 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.122 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.122 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.121 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.120 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.120 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.120 | |
| epithelial tube formation | GO:0072175 | 130 | 0.118 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.117 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.117 | |
| epithelial mesenchymal signaling involved in prostate gland development | GO:0060738 | 2 | 0.117 | |
| peptide secretion | GO:0002790 | 114 | 0.116 | |
| vagus nerve development | GO:0021564 | 3 | 0.116 | |
| regulation of system process | GO:0044057 | 200 | 0.116 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.116 | |
| endothelial cell migration | GO:0043542 | 44 | 0.115 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.115 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.115 | |
| hindbrain formation | GO:0021576 | 1 | 0.114 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.114 | |
| forebrain neuron development | GO:0021884 | 30 | 0.114 | |
| brain morphogenesis | GO:0048854 | 32 | 0.114 | |
| steroid metabolic process | GO:0008202 | 119 | 0.113 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.112 | |
| mesoderm development | GO:0007498 | 100 | 0.111 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.110 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.109 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.108 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.108 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.108 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.108 | |
| neural tube formation | GO:0001841 | 108 | 0.108 | |
| diencephalon development | GO:0021536 | 63 | 0.108 | |
| mesenchyme development | GO:0060485 | 152 | 0.107 | |
| positive regulation of heart growth | GO:0060421 | 18 | 0.106 | |
| epidermis development | GO:0008544 | 187 | 0.106 | |
| endothelium development | GO:0003158 | 45 | 0.106 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.105 | |
| spermatogenesis | GO:0007283 | 284 | 0.105 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.105 | Human |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.105 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.104 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.104 | |
| oxidation reduction process | GO:0055114 | 342 | 0.103 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.103 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.103 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.102 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.101 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.101 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.101 | |
| bone mineralization | GO:0030282 | 54 | 0.101 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.101 | |
| hormone metabolic process | GO:0042445 | 86 | 0.101 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.101 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.101 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.100 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.100 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.100 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.099 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.099 | |
| protein maturation | GO:0051604 | 176 | 0.099 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.099 | |
| biomineral tissue development | GO:0031214 | 64 | 0.099 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.099 | |
| endocytosis | GO:0006897 | 168 | 0.099 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.099 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.098 | |
| muscle fiber development | GO:0048747 | 76 | 0.098 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.097 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.097 | |
| protein secretion | GO:0009306 | 111 | 0.097 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.097 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.097 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.096 | |
| lung field specification | GO:0060424 | 3 | 0.096 | |
| regulation of skeletal muscle fiber differentiation | GO:1902809 | 3 | 0.096 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.096 | |
| coronary vasculature development | GO:0060976 | 12 | 0.096 | |
| tongue muscle cell differentiation | GO:0035981 | 2 | 0.096 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.095 | |
| transmembrane transport | GO:0055085 | 412 | 0.095 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.094 | |
| endocrine system development | GO:0035270 | 98 | 0.094 | |
| foregut regionalization | GO:0060423 | 3 | 0.094 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.094 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.094 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.093 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.093 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.092 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.092 | |
| immune effector process | GO:0002252 | 321 | 0.092 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.092 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.091 | |
| hindbrain development | GO:0030902 | 128 | 0.091 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.091 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.090 | |
| tube formation | GO:0035148 | 140 | 0.090 | |
| protein processing | GO:0016485 | 163 | 0.090 | |
| stem cell maintenance | GO:0019827 | 130 | 0.090 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.090 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.090 | |
| neural tube patterning | GO:0021532 | 43 | 0.090 | |
| endoderm development | GO:0007492 | 45 | 0.090 | |
| regulation of protein localization | GO:0032880 | 231 | 0.090 | |
| tongue development | GO:0043586 | 18 | 0.090 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.090 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.089 | |
| neural tube development | GO:0021915 | 160 | 0.087 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.087 | |
| primary neural tube formation | GO:0014020 | 95 | 0.087 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.086 | |
| somite development | GO:0061053 | 81 | 0.086 | |
| tube closure | GO:0060606 | 91 | 0.086 | |
| gland development | GO:0048732 | 330 | 0.086 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.085 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.085 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.085 | |
| bundle of his development | GO:0003166 | 4 | 0.085 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.085 | |
| cytokine secretion | GO:0050663 | 72 | 0.085 | |
| amide transport | GO:0042886 | 138 | 0.085 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.084 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.084 | |
| renal inner medulla development | GO:0072053 | 3 | 0.084 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.084 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.084 | |
| hindlimb morphogenesis | GO:0035137 | 42 | 0.084 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.084 | |
| milk ejection | GO:0060156 | 1 | 0.083 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.083 | |
| mesodermal to mesenchymal transition involved in gastrulation | GO:0060809 | 1 | 0.083 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.083 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.083 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.083 | |
| mesonephric tubule formation | GO:0072172 | 11 | 0.083 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.082 | |
| response to nutrient levels | GO:0031667 | 109 | 0.082 | |
| mitral valve development | GO:0003174 | 4 | 0.082 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.082 | |
| cardiac cell development | GO:0055006 | 41 | 0.082 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.082 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.082 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.082 | |
| tissue remodeling | GO:0048771 | 102 | 0.082 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.082 | |
| notochord development | GO:0030903 | 20 | 0.081 | |
| interferon gamma production | GO:0032609 | 67 | 0.081 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.081 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.081 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.080 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.080 | Human |
| notochord formation | GO:0014028 | 5 | 0.080 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.080 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.080 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.080 | |
| metanephric capsule formation | GO:0072266 | 1 | 0.080 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.079 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.079 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.079 | |
| renal vesicle development | GO:0072087 | 17 | 0.079 | |
| cellular response to lipid | GO:0071396 | 145 | 0.079 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.079 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.079 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.079 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.079 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.078 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.078 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.078 | |
| embryonic forelimb morphogenesis | GO:0035115 | 32 | 0.077 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.077 | |
